Egypt Edition 
MENA+ Edition 
UAE Edition 
Saudi Edition 
AI + Innovation (MENA) 
Logistics (MENA) 
Egyptian Drug Authority approves Merck antiviral pill
The Egyptian Drug Authority (EDA) has approved Merck’s antiviral covid-19 pill Molnupiravir for emergency use, making Egypt the first country…
GSK Egypt rejects Acdima’s bid to start due diligence, closing the door to a sale
GlaxoSmithKline Egypt’s board of directors has rejected a request submitted by Acdima to start due diligence on the company, GSK…
GSK is staying put — for now
GSK puts Egypt exit on the backburner: GlaxoSmithKline has shelved plans to sell its units in Egypt and Tunisia following…
GSK, Hikma end acquisition talks
Hikma Pharma won’t be acquiring GlaxoSmithKline’s Egypt unit: GSK and Hikma Pharma have agreed to end talks over a takeover…
Strong with the force, healthcare M&As are
The latest M&A activity in the red-hot healthcare sector appears to be a bidding war brewing for Alexandria Medical Services.…
GSK only has eyes for Hikma
GlaxoSmithKline (GSK) has rejected separate takeover bids from Rameda and Acdima for its Egypt arm, focusing instead on talks with…
Landmark M&A in pharma, education
The week ends with news of two landmark acquisitions, one each in pharma and education. LSE-listed Hikma Pharma plans to…